Description: MagForce AG operates in the field of nanotechnology-based cancer therapy in Germany and Poland. It offers NanoTherm, a therapy for the treatment of brain tumors; NanoPlan, a software that supports the attending physician in preparing the ideal treatment plan for the NanoTherm therapy; and NanoActivator, a magnetic field generator. MagForce AG was founded in 1997 and is headquartered in Berlin, Germany.
Home Page: www.magforce.com
Max-Planck-Strasse 3
Berlin,
12489
Germany
Phone:
49 30 308 380 0
Officers
| Name | Title |
|---|---|
| Dr. Benjamin J. Lipps | Chairman of the Management Board & CEO |
| Mr. Christian Von Volkmann M.B.A., MBA | CFO & Member of Management Board |
| Dr. Andreas Jordan | Exec. VP, Chief Scientific Officer & MD of Europe |
| Ms. Barbara Von Frankenberg | VP of Communications & Investor Relations |
| Ms. Solveig Salomon | VP of Marketing & Sales and European Commercial Director |
| Dr. Hans Joachim Hutt M.D., Ph.D. | Medical Consultant |
Exchange: F
Country: DE
Currency: Euro (€)
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0.0118 |
| Price-to-Book MRQ: | 0.0033 |
| Price-to-Sales TTM: | 2.9364 |
| IPO Date: | |
| Fiscal Year End: | December |
| Full Time Employees: | 33 |